Showing 1–50 of 531 results

  1. News |

  2. Comments and Opinion |

    • ...new look. He spoke with Asher Mullard about Takeda’s plans to...
  3. News |

  4. News |

  5. Comments and Opinion |

    • ...the transition. She spoke with Asher Mullard about the lessons the company...
  6. News |

  7. News |

  8. News |

  9. News |

  10. Comments and Opinion |

    • ...of pembrolizumab, he spoke with Asher Mullard about remaining immuno-oncology opportunities...
  11. News |

  12. News |

  13. News |

  14. News |

  15. Comments and Opinion |

  16. News |

  17. News |

  18. News |

  19. News |

  20. News |

  21. News |

  22. News |

  23. Comments and Opinion |

  24. News |

  25. News |

  26. News |

  27. Comments and Opinion |

    • ...drug discovery. She spoke with Asher Mullard about her vision for machine...
  28. News |

  29. News |

  30. News |

  31. News |

  32. Comments and Opinion |

    • ...human immunity. Hazuda spoke with Asher Mullard about the firm’s exploratory...
  33. Comments and Opinion |

    • ...muscular atrophy. He spoke with Asher Mullard about applying an engineering mindset...
  34. News |

  35. News |

  36. News |

  37. News |

  38. News |

  39. Comments and Opinion |

    • ...the works. He spoke with Asher Mullard about the future of genome...
  40. News |

  41. News |

  42. News |

  43. News |

  44. Comments and Opinion |

    • ...bispecific biologics. Jallal spoke with Asher Mullard about the opportunities for TCRs...
  45. News |

  46. News |

  47. News |

  48. News |

  49. News |

  50. Comments and Opinion |

    • ...development at scale, he told Asher Mullard. After over a year...